Target intelligence / Profile preview

Eukaryotic translation initiation factor 4A1 pseudogene 11 (EIF4A1P11)

Target
EIF4A1P11
Molecular classification
Other (pseudogene)
01

Overview

Eukaryotic translation initiation factor 4A1 pseudogene 11 (EIF4A1P11) is a segment of human DNA that closely resembles the functional *eukaryotic translation initiation factor 4A1* (EIF4A1) gene, but it does not code for an active protein product[5][6]. Pseudogenes such as EIF4A1P11 result from duplication or retrotransposition events followed by loss of function, often due to mutations (such as premature stop codons or frameshifts)[6]. While the parent gene EIF4A1 encodes an important RNA helicase involved in translation initiation, pseudogenes like EIF4A1P11 do not contribute to protein synthesis, are not classified as enzymes, receptors, or other druggable target classes, and are not currently associated with any known drug interactions, mechanism of action, biomarker roles, or disease functions in the literature[2][5][6]. Misidentification of a pseudogene as a target can confound genetic or pharmacological research[6].\n\nIf your interest is in the functional protein, see **Eukaryotic translation initiation factor 4A1 (EIF4A1)**, which is a validated target and active translation factor[3][7]. But **EIF4A1P11** specifically refers to a nonfunctional genomic copy—**not a therapeutic target**.

Other names
EIF4A1P11
02

Mechanism of action

None

03

Biological functions

None (pseudogenes are generally nonfunctional)
04

Disease associations

None (not known to play a direct disease role; not a functional gene)

Beyond the preview

Go deeper on Eukaryotic translation initiation factor 4A1 pseudogene 11 (EIF4A1P11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation initiation factor 4A1 pseudogene 11 (EIF4A1P11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call